DALIA FRASCA: Open Payments
NPI 1255917415 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,172 in 162 payments from 27 companies in 2025. Trend: 2023 $2,494 · 2024 $2,306 · 2025 $5,172
Food & beverage: $3,865Travel & lodging: $1,199Education: $108
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 11 | $1,629 |
| GlaxoSmithKline, LLC. | 23 | $486 |
| AstraZeneca Pharmaceuticals LP | 13 | $477 |
| GENZYME CORPORATION | 19 | $371 |
| JAZZ PHARMACEUTICALS INC. | 6 | $302 |
| Merck Sharp & Dohme LLC | 10 | $287 |
| Regeneron Healthcare Solutions, Inc. | 16 | $220 |
| ANI Pharmaceuticals, Inc. | 7 | $191 |
| Axsome Therapeutics, Inc. | 8 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $147 |
Products named: INSPIRE, DUPIXENT, NUCALA, TEZSPIRE, XYWAV, PURIFIED CORTROPHIN GEL, WINREVAIR, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
